-
Something wrong with this record ?
Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system
J. Zicha, Z. Dobešová, M. Behuliak, M. Pintérová, J. Kuneš, I. Vaněčková
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Calcium Channel Blockers pharmacology therapeutic use MeSH
- Hypertension drug therapy physiopathology MeSH
- Blood Pressure drug effects physiology MeSH
- Rats MeSH
- Disease Models, Animal * MeSH
- Random Allocation MeSH
- Nifedipine pharmacology therapeutic use MeSH
- Rats, Inbred SHR MeSH
- Rats, Inbred WKY MeSH
- Rats, Transgenic MeSH
- Renin-Angiotensin System drug effects physiology MeSH
- Sympathetic Nervous System drug effects physiology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
High blood pressure (BP) of spontaneously hypertensive rats (SHR) is maintained by enhanced activity of sympathetic nervous system (SNS), whereas that of Ren-2 transgenic rats (Ren-2 TGR) by increased activity of renin-angiotensin system (RAS). However, both types of hypertension are effectively attenuated by chronic blockade of L-type voltage-dependent calcium channel (L-VDCC). The aim of our study was to evaluate whether the magnitude of BP response elicited by acute nifedipine administration is proportional to the alterations of particular vasoactive systems (SNS, RAS, NO) known to modulate L-VDCC activity. We therefore studied these relationships not only in SHR, in which mean arterial pressure was modified in a wide range of 100-210 mm Hg by chronic antihypertensive treatment (captopril or hydralazine) or its withdrawal, but also in rats with augmented RAS activity such as homozygous Ren-2 TGR, pertussis toxin-treated SHR or L-NAME-treated SHR. In all studied groups the magnitude of BP response to nifedipine was proportional to actual BP level and it closely correlated with BP changes induced by acute combined blockade of RAS and SNS. BP response to nifedipine is also closely related to the degree of relative NO deficiency. This was true for both SNS- and RAS-dependent forms of genetic hypertension, suggesting common mechanisms responsible for enhanced L-VDCC opening and/or their upregulation in hypertensive animals. In conclusions, BP response to nifedipine is proportional to the vasoconstrictor activity exerted by both SNS and RAS, indicating a key importance of these two pressor systems for actual L-VDCC opening necessary for BP maintenance.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14083254
- 003
- CZ-PrNML
- 005
- 20150113080835.0
- 007
- ta
- 008
- 150102s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932717 $2 doi
- 035 __
- $a (PubMed)24397813
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Zicha, Josef, $d 1950- $7 jk01152609 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 245 10
- $a Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system / $c J. Zicha, Z. Dobešová, M. Behuliak, M. Pintérová, J. Kuneš, I. Vaněčková
- 520 9_
- $a High blood pressure (BP) of spontaneously hypertensive rats (SHR) is maintained by enhanced activity of sympathetic nervous system (SNS), whereas that of Ren-2 transgenic rats (Ren-2 TGR) by increased activity of renin-angiotensin system (RAS). However, both types of hypertension are effectively attenuated by chronic blockade of L-type voltage-dependent calcium channel (L-VDCC). The aim of our study was to evaluate whether the magnitude of BP response elicited by acute nifedipine administration is proportional to the alterations of particular vasoactive systems (SNS, RAS, NO) known to modulate L-VDCC activity. We therefore studied these relationships not only in SHR, in which mean arterial pressure was modified in a wide range of 100-210 mm Hg by chronic antihypertensive treatment (captopril or hydralazine) or its withdrawal, but also in rats with augmented RAS activity such as homozygous Ren-2 TGR, pertussis toxin-treated SHR or L-NAME-treated SHR. In all studied groups the magnitude of BP response to nifedipine was proportional to actual BP level and it closely correlated with BP changes induced by acute combined blockade of RAS and SNS. BP response to nifedipine is also closely related to the degree of relative NO deficiency. This was true for both SNS- and RAS-dependent forms of genetic hypertension, suggesting common mechanisms responsible for enhanced L-VDCC opening and/or their upregulation in hypertensive animals. In conclusions, BP response to nifedipine is proportional to the vasoconstrictor activity exerted by both SNS and RAS, indicating a key importance of these two pressor systems for actual L-VDCC opening necessary for BP maintenance.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní tlak $x účinky léků $x fyziologie $7 D001794
- 650 _2
- $a blokátory kalciových kanálů $x farmakologie $x terapeutické užití $7 D002121
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a hypertenze $x farmakoterapie $x patofyziologie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nifedipin $x farmakologie $x terapeutické užití $7 D009543
- 650 _2
- $a náhodné rozdělení $7 D011897
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani inbrední WKY $7 D011921
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a renin-angiotensin systém $x účinky léků $x fyziologie $7 D012084
- 650 _2
- $a sympatický nervový systém $x účinky léků $x fyziologie $7 D013564
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dobešová, Zdena, $d 1947- $7 xx0074152 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Behuliak, Michal $7 xx0196023 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Pintérová, Mária $7 xx0102050 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Kuneš, Josef, $d 1930- $7 jn20000710374 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Vaněčková, Ivana, $d 1964- $7 xx0030586 $u Department of Experimental Hypertension, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 1 (2014), s. 13-26
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20150102 $b ABA008
- 991 __
- $a 20150112074953 $b ABA008
- 999 __
- $a ok $b bmc $g 1057926 $s 882362
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c 1 $d 13-26 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20150102